CompanyDrug

Evopoint Biosciences Gets CDE Approval for Phase I/II Study of XNW27011 ADC

HospitalPolicy / Regulatory

China’s NHC Advances Enhanced Recovery After Surgery (ERAS) Protocols Nationwide

CompanyDrug

ChengDu ShengNuo Biotech Secures NMPA Approval for Generic Firazyr Equivalent

CompanyDeals

CanSino Biotechnology Leads RMB 500 Million Private Equity Fund for Vaccine Investments

CompanyDeals

PharmaEssentia Corporation Completes Secondary Offering of GDR Shares on Luxembourg Exchange

Company

Lee’s Pharmaceutical Holdings Ltd Reports 2022 Revenues and Pipeline Updates

CompanyDrug

Reistone Biopharma’s RSS0343 Receives NMPA Approval for Non-Cystic Fibrosis Bronchiectasis

CompanyDeals

Siemens Healthineers and China Chest Pain Center Launch Smart Training Program

CompanyDrug

Neurodawn Pharmaceutical’s Y-1 Receives NMPA Approval for Primary Intracranial Tumor Treatment

CompanyDeals

Biosion Secures Series B+ Financing to Advance Antibody-Based Therapies Pipeline

Company

Jiangsu Hengrui Pharmaceuticals Reports 2022 Revenue Dip and Increased R&D Investment

CompanyDrug

GenScript Biotech’s Subsidiary Legend Biotech Announces Positive CAR-T Therapy Results